Global Digital Respiratory Devices Market - Analysis and Forecast, 2019-2029

Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape

Published Year: 2019
SKU: BH00717SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Report Description

The global digital respiratory devices market analysis done by BIS Research highlights that the market was valued at approximately

Market Report Coverage - Digital Respiratory Devices

Base Year

2018

Market Size in 2018

$8.5 million

Forecast Period

2019-2029

Value Projection and Estimation by 2029

$334.0 million

CAGR During Forecast Period

38.26%

Number of Tables

10

Number of Pages

179

Number of Figures

105

Research Hours

 700

 

 

Market Segmentation

• Product Type – Sensors and Apps, Smart Inhalers and Nebulizers

• Indication – Asthma, Chronic obstructive Pulmonary Disease (COPD)

Regional Segmentation

• North America – U.S., Canada

• Europe – Germany, United Kingdom, France

• Asia-Pacific – Japan, China, Australia, India

Growth Drivers

• Increasing Prevalence of Respiratory Diseases

• Increasing Adoption of Digital Technology Among Individuals

• Treatment Satisfaction with Inhaled Therapy Among Individuals

Market Challenges

• Issues Related to The Accuracy and Reliability of the Device

• Availability and High Cost Associated with Digital Respiratory Devices

Market Opportunities

• Expansion into the Emerging Markets

• Predicting Future Exacerbations

Key Companies Profiled

3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca PLC., Boehringer Ingelheim International GmbH, Capsule Technologies, Inc., Cohero Health, GlaxoSmithKline PLC, Novartis AG, Propeller Health, Sensiron AG, Teva Pharmaceuticals Industries Ltd.

Key Questions Answered in this Report:

What was the total revenue generated by the global digital respiratory devices market in 2018 and how is it expected to grow durin

•    What was the total revenue generated by the global digital respiratory devices market in 2018 and how is it expected to grow during 2019-2029?
•    What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?
•    What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?
•    What are the potential business models in global digital respiratory devices market?
•    Which product type, such as sensors & apps and smart inhalers & nebulizers of the global digital respiratory system market is expected to dominate during the forecast period 2019-2029?
•    Which indication type such as asthma and chronic obstructive pulmonary disease of the global digital respiratory system market is expected to dominate during the forecast period?
•    How are pharma players planning to capitalize upon the opportunity of increasing demand for connected inhalers to improve drug sales?
•    How is the pharma industry expected to evolve in terms of drug-based devices in the future?
•    What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
•    Which are the key manufacturers in global digital respiratory devices market, and what are their contributions in the global market?

Market Overview

To cater to the needs of the population, healthcare companies have stepped forward through technology to deliver portable and comp

Over 500 million individuals are infected with chronic respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This leads to a surge in demand for better treatments and outcomes, early diagnosis, and tailored medication. To cater to the needs of the population, healthcare companies have stepped forward through technology to deliver portable and compact respiratory care devices, ultimately leading to the creation of a global market for digital respiratory devices.

Our team of industry analysts has concluded that the global respiratory devices market is expected to reach the mark of $334 million by 2029. Growth in the implementation of connected devices for the collection of large-scale anonymous data has allowed healthcare providers to formulate appropriate and innovative devices to cure respiratory illness. Several medical device companies have introduced digital respiratory devices such as sensors, apps, breathing machines, smart inhalers, and nebulizers, to provide real-time data to people.

The market is favored by multiple factors, which include substantial investments made in the field of personalized medicine, increased awareness among individuals regarding the benefits of connected inhalers, and growing adoption of sensor technologies and apps to monitor and manage inhalation of medications, among others. According to the World Health Organization (WHO), respiratory diseases are considered one of the world’s biggest health concerns.

Within the research report, the market is segmented on the basis of Product Type, Indication, and Region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

Several pharmaceutical players such as GlaxoSmithKline plc, AstraZeneca plc, Philips, Novartis AG, and Boehringer Ingelheim GmbH, among others are focusing on agreements and collaborations with the digital health companies such as Adherium Ltd. and Propeller Health Inc. for the development of smart inhalers with reduced costs and produce effective results in a minimal period of time. Key players are actively investing in the development of sensor-integrated inhalers and digital engagement tools that enable the recording of inhaler medications and provide new insights and support to allow better management of asthma and COPD patients.

On the basis of region, North America is expected to retain a leading position throughout the forecast period 2019-2029, followed by Europe. This is a result of the presence of leading industry players in these regions, a higher adoption rate of advanced medical devices, rise in per capita income of individuals, among others. Among all the available treatment methods, inhalation is considered the most effective for asthma and COPD patients that yields results in the least possible time.

Other geographies such as China, India, Japan, and several countries of Latin America, Middle East, and Africa, comprise a massive population with a high risk of respiratory diseases and, ultimately, offer great market expansion opportunities.

Table of Contents

1 Market Overview

          1.1    Introduction
          1.2    Digital Respiratory Devices Market Ecosystem
          1.3    Assumptions and Limitations

2 Market Dynamics

          2.1    Impact Analysis
          2.2    Market Drivers
                   2.2.1    Increasing Prevalence of Respiratory Diseases
                   2.2.2    Increasing Adoption of Digital Technology Among Individuals
                   2.2.3    Treatment Satisfaction with Inhaled Therapy Among Individuals
          2.3    Market Restraints
                   2.3.1    Issues Related to The Accuracy and Reliability of the Device
                   2.3.2    Availability and High Cost Associated with Digital Respiratory Devices
          2.4    Market Opportunities
                   2.4.1    Expansion into the Emerging Markets
                   2.4.2    Predicting Future Exacerbations

3 Competitive Landscape

          3.1    Key Developments and Strategies
                   3.1.1    Agreements and Collaborations
                   3.1.2    Product Approvals
                   3.1.3    Mergers and Acquisitions
                   3.1.4    Awards and Recognitions
                   3.1.5    Investments, Funding, and Business Expansion
                   3.1.6    Product Launches
          3.2    Market Share Analysis
          3.3    Industry Attractiveness
                   3.3.1    Bargaining Power of Suppliers
                   3.3.2    Bargaining Power of Buyer
                   3.3.3    Threat of New Entrants
                   3.3.4    Threat of Substitute Products
                   3.3.5    Intensity of Competitive Rivalry

4 Industry Insights

          4.1    Opportunity Map Analysis of Smart Inhalers and Nebulizers
          4.2    Smart Inhaler Value Propositions for Stakeholders
          4.3    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
          4.4    Business Models for Digital Respiratory Devices Market

5 Global Digital Respiratory Devices Market (by Product Type)

          5.1    Sensors and Apps
          5.2    Smart Inhalers and Nebulizers

6 Global Digital Respiratory Devices Market (by Indication)

          6.1    Asthma
          6.2    Chronic Obstructive Pulmonary Disease (COPD)

7 Global Digital Respiratory Devices Market (by Region)

          7.1    North America
                   7.1.1    U.S.
                   7.1.2    Canada
          7.2    Europe
                   7.2.1    Germany
                   7.2.2    U.K.
                   7.2.3    France
                   7.2.4    Rest-of-Europe
          7.3    Asia-Pacific (APAC)
                   7.3.1    Japan
                   7.3.2    China
                   7.3.3    Australia
                   7.3.4    India
                   7.3.5    Rest-of-Asia-Pacific (RoAPAC)
                   7.3.6    Rest-of-the-World (RoW)

8 Company Profiles

          8.1    3M Health Care Limited
                   8.1.1    Company Overview
                   8.1.2    Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market.
                   8.1.3    Financials
                               8.1.3.1    Key Insights on the Financial Health of the Company
                   8.1.4    SWOT Analysis
          8.2    Adherium Limited
                   8.2.1    Company Overview
                   8.2.2    Role of Adherium Limited in the Global Digital Respiratory Devices Market.
                   8.2.3    Financials
                               8.2.3.1    Key Insights on the Financial Health of the Company
                   8.2.4    SWOT Analysis
          8.3    Amiko Digital Health Limited
                   8.3.1    Company Overview
                   8.3.2    Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
                   8.3.3    SWOT Analysis
          8.4    AstraZeneca plc
                   8.4.1    Company Overview
                   8.4.2    Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
                   8.4.3    Financials
                               8.4.3.1    Key Insights on the Financial Health of the Company
                   8.4.4    SWOT Analysis
          8.5    Boehringer Ingelheim International GmbH
                   8.5.1    Company overview
                   8.5.2    Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
                   8.5.3    Financials
                               8.5.3.1    Key Insights on the Financial Health of the Company
                   8.5.4    SWOT Analysis
          8.6    Capsule Technologies, Inc.
                   8.6.1    Company Overview
                   8.6.2    Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
                   8.6.3    SWOT Analysis
          8.7    Cohero Health
                   8.7.1    Company Overview
                   8.7.2    Role of Cohero Health in the Global Digital Respiratory Devices Market
                   8.7.3    SWOT Analysis
          8.8    GlaxoSmithKline plc
                   8.8.1    Company overview
                   8.8.2    Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
                   8.8.3    Financials
                               8.8.3.1    Key Insights on the Financial Health of the Company
                   8.8.4    SWOT Analysis
          8.9    Novartis AG
                   8.9.1    Company overview
                   8.9.2    Role of Novartis AG in the Global Digital Respiratory Devices Market
                   8.9.3    Financials
                               8.9.3.1    Key Insights on the Financial Health of the Company
                   8.9.4    SWOT Analysis
         8.10   Propeller Health
                   8.10.1    Company Overview
                   8.10.2    Role of Propeller Health in the Global Digital Respiratory Devices Market
                   8.10.3    SWOT Analysis
         8.11   Sensiron AG
                   8.11.1    Company overview
                   8.11.2    Role of Sensiron AG in the Global Digital Respiratory Devices Market
                   8.11.3    Financials
                                 8.11.3.1    Key Insights on the Financial Health of the Company
                   8.11.4    SWOT Analysis
         8.12   Teva Pharmaceuticals Industries Ltd.
                   8.12.1    Company Overview
                   8.12.2    Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
                   8.12.3    Financials
                                 8.12.3.1    Key Insights on the Financial Health of the Company
                   8.12.4    SWOT Analysis

9 Research Scope and Methodology

          9.1    Product Definition
          9.2    Scope of the Research Study

List of Tables

Table 1: A Research and Facilitation Framework    
Table 2: Impact Analysis of Global Digital Respiratory Devices Market    
Table 2.1: Impact Analysis of Global Digital Respiratory Devices Market    
Table 2.2: Prevalence of Asthma in Key Countries, 2015-2017    
Table 2.3: Prevalence of COPD in Key Countries, 2015-2017    
Table 4.1: Smart Inhaler Value Propositions for Stakeholders    
Table 4.2: Different Data Revenue Streams    
Table 5.1: Smart Inhalers in Pipeline    
Table 6.1: Incidence of Asthma in Key Countries, 2015-2017    
Table 6.2: Incidence of COPD in Key Countries, 2015-2017

List of Figures

Figure 1:    Opportunities for Clinical Benefit
Figure 2:    Global Digital Respiratory Devices Market, 2018-2029
Figure 3:    Dominating Segments of Global Digital Respiratory Devices Market, 2018 and 2029
Figure 4:    Global Digital Respiratory Devices Market (by Product Type), 2018 and 2029
Figure 5:    Global Digital Respiratory Devices Market (by Indication), 2018 and 2029
Figure 6:    Global Digital Respiratory Devices Market (by Region), 2018 and 2029
Figure 7:    Strategies Incorporated to Expand the Global Reach
Figure 8:    Go-To-Market Strategy
Figure 1.1:    Digital Respiratory Devices Market Workflow
Figure 1.2:    Smart Inhalers and Data Flow
Figure 1.3:    Digital Respiratory Devices Market Ecosystem
Figure 3.1:    Competitive Landscape, January 2015 - May 2019
Figure 3.2:    Share of Key Developments and Strategies, January 2015- May 2019
Figure 3.3:    Agreements and Collaborations Share (by Companies), January 2015- May 2019
Figure 3.4:    Product Approvals Share (by Companies), January 2015- May 2019
Figure 3.5:    Mergers and Acquisitions Share (by Companies), January 2015- May 2019
Figure 3.6:    Awards and Recognitions Share (by Companies), January 2015- May 2019
Figure 3.7:    Investments, Fundings, and Business Expansions Share (by Companies), January 2015- May 2019
Figure 3.8:    Product Launches Share (by Companies), January 2015- May 2019
Figure 3.9:    Market Share Analysis, 2017 and 2018
Figure 3.10:    Porter’s Five Forces Analysis
Figure 3.11:    Bargaining Power of Suppliers: Overall Impact, 2018-2029
Figure 3.12:    Bargaining Power of Buyers: Overall Impact, 2018-2029
Figure 3.13:    Threat of New Entrant: Overall Impact, 2018-2029
Figure 3.14:    Threat of Substitute Products: Overall Impact, 2018-2029
Figure 3.15:    Intensity of Competitive Rivalry: Overall Impact, 2018-2029
Figure 4.1:    Opportunity Map Analysis of Digital Respiratory Devices Market
Figure 4.2:    Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals
Figure 5.1:    Global Digital Respiratory Devices Market (by Product Type)
Figure 5.2:    Global Digital Respiratory Devices Market Share (by Product Type), 2018 and 2029
Figure 5.3:    Global Digital Respiratory Devices Market (by Sensors and Apps), 2018-2029
Figure 5.4:    Global Digital Respiratory Devices Market (by Smart Inhalers and Nebulizers), 2018-2029
Figure 6.1:    Global Digital Respiratory Devices Market (by Indication)
Figure 6.2:    Global Digital Respiratory Devices Market Share (by Indication), 2018 and 2029
Figure 6.3:    Global Digital Respiratory Devices Market (by Asthma), 2018-2029
Figure 6.4:    Global Digital Respiratory Devices Market (by COPD), 2018-2029
Figure 7.1:    Global Digital Respiratory Devices Market (by Region)
Figure 7.2:    Global Digital Respiratory Devices Market (by Region), 2018-2029
Figure 7.3:    North America Digital Respiratory Devices Market, 2018-2029
Figure 7.4:    North America Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.5:    U.S. Digital Respiratory Devices Market, 2018-2029
Figure 7.6:    Canada Digital Respiratory Devices Market, 2018-2029
Figure 7.7:    Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.8:    Europe Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.9:    Germany Digital Respiratory Devices Market, 2018-2029
Figure 7.10:    U.K. Digital Respiratory Devices Market, 2018-2029
Figure 7.11:    France Digital Respiratory Devices Market, 2018-2029
Figure 7.12:    Rest-of-Europe Digital Respiratory Devices Market, 2018-2029
Figure 7.13:    Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.14:    Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2029
Figure 7.15:    Japan Digital Respiratory Devices Market, 2018-2029
Figure 7.16:    China Digital Respiratory Devices Market, 2018-2029
Figure 7.17:    Australia Digital Respiratory Devices Market, 2018-2029
Figure 7.18:    India Digital Respiratory Devices Market, 2018-2029
Figure 7.19:    Rest-of-Asia-Pacific Digital Respiratory Devices Market, 2018-2029
Figure 7.20:    Rest-of-the-World Digital Respiratory Devices Market, 2018-2029
Figure 8.1:    Shares of Key Company Profiles
Figure 8.2:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.3:    Overall Financials, 2016-2018
Figure 8.4:    Net Revenue (by Business Segment), 2016-2018
Figure 8.5:    Net Revenue (by Region), 2016-2018
Figure 8.6:    R& D Expense, 2016-2018
Figure 8.7:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.8:    Overall Financials, 2016-2018
Figure 8.9:    R&D Expense, 2016-2018
Figure 8.10:    Amiko Digital Health Limited: Product Offerings
Figure 8.11:    AstraZeneca plc: Product Offerings
Figure 8.12:    AstraZeneca plc: Overall Financials, 2016-2018
Figure 8.13:    AstraZeneca plc: Net Revenue (by Region), 2016-2018
Figure 8.14:    AstraZeneca plc: R&D Expense, 2016-2018
Figure 8.15:    Boehringer Ingelheim International GmbH: Product Offerings
Figure 8.16:    Boehringer Ingelheim International GmbH: Overall Financials, 2016-2018
Figure 8.17:    Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2016-2018
Figure 8.18:    Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2016-2018
Figure 8.19:    Boehringer Ingelheim International GmbH: R& D Expense, 2016-2018
Figure 8.20:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.21:    GlaxoSmithKline plc: Product Offerings
Figure 8.22:    GlaxoSmithKline plc: Overall Financials, 2016-2018
Figure 8.23:    GlaxoSmithKline plc Net Revenue (by Business Segment), 2016-2018
Figure 8.24:    GlaxoSmithKline plc: Net Revenue (by Region), 2016-2018
Figure 8.25:    GlaxoSmithKline plc: R& D Expense, 2016-2018
Figure 8.26:    Novartis AG: Product Offerings
Figure 8.27:    Novartis AG: Overall Financials, 2016-2018
Figure 8.28:    Novartis AG Net Revenue (by Business Segment), 2016-2018
Figure 8.29:    Novartis AG: Net Revenue (by Region), 2016-2018
Figure 8.30:    Novartis AG: R& D Expense, 2016-2018
Figure 8.31:    Propeller Health: Product Offerings for Digital Respiratory Devices Market
Figure 8.32:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.33:    Overall Financials, 2017-2018
Figure 8.34:    Net Revenue (by Business Segment), 2017-2018
Figure 8.35:    Net Revenue (by Region), 2017-2018
Figure 8.36:    R&D Expense, 2016-2018
Figure 8.37:    Product Offerings for Global Digital Respiratory Devices Market
Figure 8.38:    Overall Financials, 2016-2018
Figure 8.39:    Net Revenue (by Business Segment), 2017-2018
Figure 8.40:    R&D Expense, 2016-2018
Figure 9.1:    Global Digital Respiratory Devices Market Segmentation
Figure 9.2:    Research Methodology
Figure 9.3:    Primary Research
Figure 9.4:    Secondary Research
Figure 9.5:    Data Triangulation
Figure 9.6:    Bottom-up Approach (Segment-wise Analysis)
Figure 9.7:    Top-down Approach (Segment-wise Analysis)
Figure 9.8:    Assumptions and Limitations
Figure 9.9:    Considered Factors for Data Prediction and Modeling

Table
of Contents

Request a Sample

You may also like

Published Year: 2019

Global Precision Medicine Market: Focus on Precision Medicine Ecosystem, Applications, 13 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global precision medicine market is anticipated to reach $216.75 billion by 2028,...

 

Global Digital Respiratory Devices Market - Analysis and Forecast, 2019-2029

Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape